Before approving SS-31 (10mg / 50mg) for internal use, align catalog data with batch COA records. SS-31 COA and Batch Review Notes focuses on Mitochondrial Research sourcing via sulanpeptide.vip.
SS-31, also known as Elamipretide, is a mitochondria-targeted tetrapeptide used in laboratory research on mitochondrial membrane models, cardiolipin-associated systems, oxidative-stress pathways, and peptide localization studies.
SS-31 (elamipretide) concentrates in inner mitochondrial membrane via cardiolipin interaction, stabilizing electron transport chain complex organization under oxidative stress. Research measures mitochondrial superoxide, ATP production, and cytochrome c retention in cardiomyocyte and skeletal muscle cell stress models.
Seahorse XF mitochondrial stress tests, MitoSOX fluorescence, and cardiolipin peroxidation assays validate SS-31 mechanism studies. Steinhorn and Wallace group publications link elamipretide to Barth syndrome and heart failure mitochondrial rescue models in peer-reviewed cardiology research.
Cross-check CAS 736992-21-5 and purity target ≥ 99.0%; archive approved PDFs with internal sample IDs. Janoshik records for SS-31, when listed at sulanpeptide.vip/coa, should be verified by task number and unique key before sample release.
COA review: Match COA product name, lot, test date, and HPLC purity to vial labels for SS-31.
Catalog identifiers for SS-31: CAS 736992-21-5, Formula: C32H49N9O5. MW 639.79 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Migration and receptor assays for SS-31 are sensitive to degradation—confirm lot purity before release.
Request method details on SS-31 COA if purity is reported without chromatogram context.
Janoshik-verified SS-31 batches listed at sulanpeptide.vip/coa add third-party confirmation when task number and unique key validate successfully. Failed verification should trigger quarantine until the supplier clarifies batch status. Migration and signaling assays using SS-31 are sensitive to oxidized or aggregated peptide. Lot release should include visual inspection (White Lyophilized Powder) plus COA approval—not catalog marketing text alone.
COA review for SS-31 starts with identity: product name, lot, and specification (10mg / 50mg) must match the vial label character-for-character. QA teams then confirm CAS 736992-21-5 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows. Chromatographic context on SS-31 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details.
Archive SS-31 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step.
Chromatographic context on SS-31 COA documents matters when purity is near your laboratory cutoff. Request integration traces or method summary if the PDF lists only a numeric HPLC result without column or gradient details. Archive SS-31 COA PDFs using filenames tied to internal sample IDs (for example LAB-2026-0042_COA.pdf). Link reconstitution logs and aliquot records to the same ID chain so audits retrieve documentation in one step.
COA review for SS-31 starts with identity: product name, lot, and specification (10mg / 50mg) must match the vial label character-for-character. QA teams then confirm CAS 736992-21-5 and purity target ≥ 99.0% against internal release thresholds before material enters cell or animal workflows.
SS-31 from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.